Kingdom Capital
Kingdom Capital is a venture capital and private equity firm established in 2016 and based in Chesterfield, Missouri. The firm focuses on investing in early and growth stage, as well as mature and established companies, particularly within the healthcare, medical, technology, media, and real estate sectors. Kingdom Capital emphasizes sectors such as artificial intelligence, data science, therapeutics, medical devices, diagnostics, healthcare IT, and life science tools. The firm also fosters a values-driven investment approach, connecting its investors with philanthropic initiatives through the Kingdom Capital Foundation, thereby creating a comprehensive ecosystem that facilitates the flow of capital to its philanthropic community.
AstrumU, Inc. operates a technology-driven platform that connects employers with recent graduates by quantifying the return on educational investment. Founded in 2017 and based in Kirkland, Washington, with an additional office in Kansas City, the company aims to enhance industry engagement and promote economic mobility. The AstrumU platform utilizes artificial intelligence to analyze data from students, educational institutions, and employers, providing predictive insights that help forecast the value of educational experiences in the labor market. This approach enables institutions and lifelong learners to make informed decisions about enrollment and career development based on verifiable skills and outcomes, fostering a more transparent and efficient marketplace for talent.
IntEngine is a Beijing-based robotics company specializing in the development of software algorithms and chip hardware technology aimed at enhancing efficiency in daily life. The company focuses on deep learning and machine learning algorithms, providing tailored neural networks and terminal equipment. Additionally, IntEngine assists in upgrading security monitoring systems, offering advanced digitalization solutions for industrial users. Through its innovative approach, IntEngine aims to improve operational efficiency and security in various sectors.
Canopy Biosciences is a biotechnology company based in St. Louis, Missouri, founded in 2016. It specializes in providing research tools and services for genetic engineering and personalized medicine. The company's gene editing technology, known as TUNR, works by targeting translation elongation to insert polyA tracks into specific coding regions of the genome. This process effectively reduces the levels of mRNA transcribed from the gene, leading to a suppression of protein expression. The technology was initially developed by Professors Sergej Djuranovic and Rachel Green at Washington University School of Medicine and Johns Hopkins University, respectively. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.